| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 8.13× | 8.13× | 7.06× | 5.90× | 6.81× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.28× | 0.28× | 0.30× | 0.33× | 0.24× | ||
| −1.90× | −1.90× | 1.22× | −0.23× | −3.17× | ||
| −1.26× | −1.26× | 0.87× | −0.13× | −1.71× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 6.81 | 5.90 | 7.06 | 8.13 | 8.13 | |
| Asset Turnover | 0.24 | 0.33 | 0.30 | 0.28 | 0.28 | |
| Cash Conversion (CFO/Net Income) | -3.17 | -0.23 | 1.22 | -1.90 | -1.90 | |
| CFO/EBITDA | -1.71 | -0.13 | 0.87 | -1.26 | -1.26 |